TRPM7 was previously discovered to be a potent driver of oncogenic transformation through collaboration with MMP2 and cyclin D1 and is closely associated with the hallmark capabilities of cancers, such as sustained chronic proliferation, evasion of growth suppressors, and activation of invasion and metastasis [34–36]. This evidence concerns the gene MMP2 and cancer.